Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Ca...

by Jonathan W. Goldman, David M. Waterhouse, Ben George, Peter J. O'Dwyer, Rafia Bhore, Sibabrata Banerjee, Larry Lyons, Chrystal U. Louis, Teng Jin Ong, Karen Kelly
Published 2019-11-01

A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic...

by Vaibhav Sahai, M. Wasif Saif, Aparna Kalyan, Philip A. Philip, Caio M. Rocha-Lima, Allyson Ocean, Michael S. Ondovik, Diane M. Simeone, Sibabrata Banerjee, Rafia Bhore, Chrystal U. Louis, Vincent Picozzi
Published 2019-09-01